Spyre Therapeutics, Inc. — SCHEDULE 13G/A Filings
6 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Spyre Therapeutics, Inc. (SYRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Spyre Therapeutics, Inc. has filed 6 SCHEDULE 13G/A documents with the SEC since 2015. To view all SEC filings by Spyre Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002337 | Mar 27, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-26-002024 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002469 | Jul 16, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-004231 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-021223 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-020484 | Feb 14, 2025 | — |